Novel anti-suprabasin antibodies may contribute to the pathogenesis of neuropsychiatric systemic lupus erythematosus

Novel anti-suprabasin antibodies may contribute to the pathogenesis of neuropsychiatric systemic lupus erythematosus

Copyright © 2017 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 193(2018) vom: 10. Aug., Seite 123-130
1. Verfasser: Ichinose, Kunihiro (VerfasserIn)
Weitere Verfasser: Ohyama, Kaname, Furukawa, Kaori, Higuchi, Osamu, Mukaino, Akihiro, Satoh, Katsuya, Nakane, Shunya, Shimizu, Toshimasa, Umeda, Masataka, Fukui, Shoichi, Nishino, Ayako, Nakajima, Hideki, Koga, Tomohiro, Kawashiri, Shin-Ya, Iwamoto, Naoki, Tamai, Mami, Nakamura, Hideki, Origuchi, Tomoki, Yoshida, Mari, Kuroda, Naotaka, Kawakami, Atsushi
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2018
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, Non-U.S. Gov't Cerebrospinal fluid Immune complexes Neuropsychiatric systemic lupus erythematosus Suprabasin Antigen-Antibody Complex Antigens, Differentiation Autoantibodies Autoantigens mehr... Neoplasm Proteins SBSN protein, human
LEADER 01000caa a22002652 4500
001 NLM27828518X
003 DE-627
005 20250222160329.0
007 cr uuu---uuuuu
008 231225s2018 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.clim.2017.11.006  |2 doi 
028 5 2 |a pubmed25n0927.xml 
035 |a (DE-627)NLM27828518X 
035 |a (NLM)29162406 
035 |a (PII)S1521-6616(17)30593-4 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Ichinose, Kunihiro  |e verfasserin  |4 aut 
245 1 0 |a Novel anti-suprabasin antibodies may contribute to the pathogenesis of neuropsychiatric systemic lupus erythematosus 
264 1 |c 2018 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 27.08.2019 
500 |a Date Revised 27.08.2019 
500 |a published: Print-Electronic 
500 |a CommentIn: Clin Immunol. 2018 Aug;193:131-132. doi: 10.1016/j.clim.2017.11.013. - PMID 29197637 
500 |a Citation Status MEDLINE 
520 |a Copyright © 2017 Elsevier Inc. All rights reserved. 
520 |a Neuropsychiatric systemic lupus erythematosus (NPSLE) is often difficult to diagnose and distinguish from other diseases, because no NPSLE-specific antibodies have been identified. We developed a novel proteomic strategy for identifying and profiling antigens in immune complexes in the cerebrospinal fluid (CSF), and applied this strategy to 26 NPSLE patients. As controls, we also included 25 SLE patients without neuropsychiatric manifestations (SLE), 15 with relapsing remitting multiple sclerosis (MS) and 10 with normal pressure hydrocephalus (NPH). We identified immune complexes of suprabasin (SBSN) in the CSF of the NPSLE group. The titer of anti-SBSN antibodies was significantly higher in the CSF of the NPSLE group compared to those of the SLE, MS and NPH groups. Microarray data showed that the senescence and autophagy pathways were significantly changed in astrocytes exposed to anti-SBSN antibodies. Our findings indicate that SBSN could be a novel autoantibody for the evaluation of suspected NPSLE 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 4 |a Cerebrospinal fluid 
650 4 |a Immune complexes 
650 4 |a Neuropsychiatric systemic lupus erythematosus 
650 4 |a Suprabasin 
650 7 |a Antigen-Antibody Complex  |2 NLM 
650 7 |a Antigens, Differentiation  |2 NLM 
650 7 |a Autoantibodies  |2 NLM 
650 7 |a Autoantigens  |2 NLM 
650 7 |a Neoplasm Proteins  |2 NLM 
650 7 |a SBSN protein, human  |2 NLM 
700 1 |a Ohyama, Kaname  |e verfasserin  |4 aut 
700 1 |a Furukawa, Kaori  |e verfasserin  |4 aut 
700 1 |a Higuchi, Osamu  |e verfasserin  |4 aut 
700 1 |a Mukaino, Akihiro  |e verfasserin  |4 aut 
700 1 |a Satoh, Katsuya  |e verfasserin  |4 aut 
700 1 |a Nakane, Shunya  |e verfasserin  |4 aut 
700 1 |a Shimizu, Toshimasa  |e verfasserin  |4 aut 
700 1 |a Umeda, Masataka  |e verfasserin  |4 aut 
700 1 |a Fukui, Shoichi  |e verfasserin  |4 aut 
700 1 |a Nishino, Ayako  |e verfasserin  |4 aut 
700 1 |a Nakajima, Hideki  |e verfasserin  |4 aut 
700 1 |a Koga, Tomohiro  |e verfasserin  |4 aut 
700 1 |a Kawashiri, Shin-Ya  |e verfasserin  |4 aut 
700 1 |a Iwamoto, Naoki  |e verfasserin  |4 aut 
700 1 |a Tamai, Mami  |e verfasserin  |4 aut 
700 1 |a Nakamura, Hideki  |e verfasserin  |4 aut 
700 1 |a Origuchi, Tomoki  |e verfasserin  |4 aut 
700 1 |a Yoshida, Mari  |e verfasserin  |4 aut 
700 1 |a Kuroda, Naotaka  |e verfasserin  |4 aut 
700 1 |a Kawakami, Atsushi  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 193(2018) vom: 10. Aug., Seite 123-130  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnns 
773 1 8 |g volume:193  |g year:2018  |g day:10  |g month:08  |g pages:123-130 
856 4 0 |u http://dx.doi.org/10.1016/j.clim.2017.11.006  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 193  |j 2018  |b 10  |c 08  |h 123-130